Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Nanoparticles in Cancer Immunotherapies: An Innovative Strategy Publisher Pubmed



Nasirmoghadas P1 ; Mousakhani A2 ; Behzad F3 ; Beheshtkhoo N4 ; Hassanzadeh A5 ; Nikoo M6, 7 ; Mehrabi M8 ; Kouhbanani MAJ4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  2. 2. Department of Plant Sciences, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran
  3. 3. Research Institute for Fundamental Sciences (RIFS), University of Tabriz, Tabriz, Iran
  4. 4. Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Immunology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
  7. 7. Helal Iran Pharmaceutical and Clinical Complex, Tehran, Iran
  8. 8. Department of Medical Nanotechnology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran

Source: Biotechnology Progress Published:2021


Abstract

Cancer has been one of the most significant causes of mortality, worldwide. Cancer immunotherapy has recently emerged as a competent, cancer-fighting clinical strategy. Nevertheless, due to the difficulty of such treatments, costs, and off-target adverse effects, the implementation of cancer immunotherapy described by the antigen-presenting cell (APC) vaccine and chimeric antigen receptor T cell therapy ex vivo in large clinical trials have been limited. Nowadays, the nanoparticles theranostic system as a promising target-based modality provides new opportunities to improve cancer immunotherapy difficulties and reduce their adverse effects. Meanwhile, the appropriate engineering of nanoparticles taking into consideration nanoparticle characteristics, such as, size, shape, and surface features, as well as the use of these physicochemical properties for suitable biological interactions, provides new possibilities for the application of nanoparticles in cancer immunotherapy. In this review article, we focus on the latest state-of-the-art nanoparticle-based antigen/adjuvant delivery vehicle strategies to professional APCs and engineering specific T lymphocyte required for improving the efficiency of tumor-specific immunotherapy. © 2020 American Institute of Chemical Engineers
Related Docs
View other Related Docs
1. Nanomedicine for Improvement of Dendritic Cell-Based Cancer Immunotherapy, International Immunopharmacology (2020)
2. Polymeric Nanoparticles for Dna Vaccine-Based Cancer Immunotherapy: A Review, Biotechnology Letters (2023)
3. Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy, Clinical and Translational Oncology (2023)
4. Biomaterial-Based Delivery Platforms for Transdermal Immunotherapy, Biomedicine and Pharmacotherapy (2023)
5. In-Vitro and In-Vivo Comparison of Rsag1-Loaded Plga Prepared by Encapsulation and Adsorption Methods As an Efficient Vaccine Against Toxoplasma Gondii”, Journal of Drug Delivery Science and Technology (2020)
6. Nanovaccines for Cancer Immunotherapy: Focusing on Complex Formation Between Adjuvant and Antigen, International Immunopharmacology (2023)
7. Genetically Modified Immune Cells Targeting Tumor Antigens, Pharmacology and Therapeutics (2020)
8. Smart Bio-Encapsulation for Immunotherapy, Smart Nanomaterials for Bioencapsulation (2022)
Experts (# of related papers)
View all Related Experts
Fatemeh Atyabi (7)
Nima Rezaei (5)
Other Related Docs
9. Folate-Conjugated Gold Nanoparticle As a New Nanoplatform for Targeted Cancer Therapy, Journal of Cancer Research and Clinical Oncology (2016)
10. Synergistic Effect of Rsag1 and Rgra2 Antigens Formulated in Plga Microspheres in Eliciting Immune Protection Against Toxoplasama Gondii, Experimental Parasitology (2016)
11. Self-Assembled Peptide/Polymer Hybrid Nanoplatform for Cancer Immunostimulating Therapies, Drug Delivery and Translational Research (2024)
12. Genetically Engineered Mesenchymal Stem Cells: Targeted Delivery of Immunomodulatory Agents for Tumor Eradication, Cancer Gene Therapy (2020)
13. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
14. Glyco-Nanoparticles: New Drug Delivery Systems in Cancer Therapy, Seminars in Cancer Biology (2021)
15. Metallic Nanoparticles for the Modulation of Tumor Microenvironment; a New Horizon, Frontiers in Bioengineering and Biotechnology (2022)
16. Bioavailability, Biodistribution, and Toxicity of Fluorescent Metal Nanoclusters, Luminescent Metal Nanoclusters: Synthesis# Characterization# and Applications (2022)
17. Does Pharmacodynamics of Drugs Change After Presenting Them As Na-Noparticles Like Their Pharmacokinetics?, Current Drug Targets (2020)
18. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)
19. New Methods in the Diagnosis of Cancer and Gene Therapy of Cancer Based on Nanoparticles, Cancer Gene Therapy (2017)
20. Nexus Between in Silico and in Vivo Models to Enhance Clinical Translation of Nanomedicine, Nano Today (2021)
21. Folate-Conjugated Nanoparticles As a Potent Therapeutic Approach in Targeted Cancer Therapy, Tumor Biology (2015)
22. Nanotechnology for Delivery of Gemcitabine to Treat Pancreatic Cancer, Biomedicine and Pharmacotherapy (2017)
23. Recent Advances on Biocompatible and Biodegradable Nanoparticles As Gene Carriers, Expert Opinion on Biological Therapy (2016)
24. Mesenchymal Stromal Cells and Car-T Cells in Regenerative Medicine: The Homing Procedure and Their Effective Parameters, European Journal of Haematology (2024)
25. Silencing of Il-6 and Stat3 by Sirna Loaded Hyaluronate-N,N,N-Trimethyl Chitosan Nanoparticles Potently Reduces Cancer Cell Progression, International Journal of Biological Macromolecules (2020)
26. Chimeric Antigen Receptor T-Cell Therapy for Breast Cancer, Future Oncology (2021)
27. Self-Assembling Peptide Epitopes As Novel Platform for Anticancer Vaccination, Molecular Pharmaceutics (2017)
28. Optimization of Docetaxel Loading Conditions in Liposomes: Proposing Potential Products for Metastatic Breast Carcinoma Chemotherapy, Scientific Reports (2020)
29. Predictive and Therapeutic Biomarkers in Chimeric Antigen Receptor T-Cell Therapy: A Clinical Perspective, Journal of Cellular Physiology (2019)
30. Controlled Anti-Cancer Drug Release Through Advanced Nano-Drug Delivery Systems: Static and Dynamic Targeting Strategies, Journal of Controlled Release (2020)
31. Biomimetic Nanotechnology for Cancer Immunotherapy: State of the Art and Future Perspective, International Journal of Pharmaceutics (2024)
32. Novel Car T Therapy Is a Ray of Hope in the Treatment of Seriously Ill Aml Patients, Stem Cell Research and Therapy (2021)
33. Immunotherapy in Aml: A Brief Review on Emerging Strategies, Clinical and Translational Oncology (2021)
34. Lipid-Based Nanoparticles for Drug Delivery Systems, Characterization and Biology of Nanomaterials for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery (2018)
35. Ph-Sensitive Stimulus-Responsive Nanocarriers for Targeted Delivery of Therapeutic Agents, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2016)
36. Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells, Frontiers in Immunology (2018)
37. Ignoring the Modeling Approaches: Towards the Shadowy Paths in Nanomedicine, Journal of Controlled Release (2018)
38. Functionalized Nanoscale Β-1,3-Glucan to Improve Her2 + Breast Cancer Therapy: In Vitro and in Vivo Study, Journal of Controlled Release (2015)
39. Retinal Tissue Engineering: Regenerative and Drug Delivery Approaches, Current Stem Cell Research and Therapy (2023)
40. Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-Β-Glycyrrhetinic Acid by Albumin-Conjugated Plga Nanoparticles, Drug Research (2015)
41. Therapeutic and Diagnostic Applications of Nanoparticles in the Management of Covid-19: A Comprehensive Overview, Virology Journal (2022)
42. Dosimetry and Radioenhancement Comparison of Gold Nanoparticles in Kilovoltage and Megavoltage Radiotherapy Using Magat Polymer Gel Dosimeter, Journal of Biomedical Physics and Engineering (2019)
43. T Cell Engineered With a Novel Nanobody-Based Chimeric Antigen Receptor Against Vegfr2 As a Candidate for Tumor Immunotherapy, IUBMB Life (2019)
44. The Chemotherapeutic Potential of Doxorubicin-Loaded Peg-B-Plga Nanopolymersomes in Mouse Breast Cancer Model, European Journal of Pharmaceutics and Biopharmaceutics (2015)
45. Therapeutic Roles of Car T Cells in Infectious Diseases: Clinical Lessons Learnt From Cancer, Reviews in Medical Virology (2022)
46. Combining Nanotechnology and Gas Plasma As an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication, Oxidative Medicine and Cellular Longevity (2021)
47. In Vitro and in Vivo Evaluation of Therapy Targeting Epithelial-Cell Adhesion-Molecule Aptamers for Non-Small Cell Lung Cancer, Journal of Controlled Release (2015)
48. Therapeutic Efficacy of Cisplatin Thermosensitive Liposomes Upon Mild Hyperthermia in C26 Tumor Bearing Balb/C Mice, Molecular Pharmaceutics (2017)
49. Biocompatibility and Nanostructured Materials: Applications in Nanomedicine, Artificial Cells# Nanomedicine and Biotechnology (2017)
50. Nanoparticles: Novel Vehicles in Treatment of Glioblastoma, Biomedicine and Pharmacotherapy (2016)